Form 8-K - Current report:
SEC Accession No. 0000950170-23-043949
Filing Date
2023-08-22
Accepted
2023-08-22 16:59:57
Documents
12
Period of Report
2023-08-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K gern-20230821.htm   iXBRL 8-K 56865
  Complete submission text file 0000950170-23-043949.txt   174003

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230821_pre.xml EX-101.PRE 10889
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230821_lab.xml EX-101.LAB 13360
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230821.xsd EX-101.SCH 2367
6 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230821_htm.xml XML 4699
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 231194384
SIC: 2834 Pharmaceutical Preparations